ArticleThe Journal of clinical endocrinology and metabolism2014

α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.

Peter A Gottlieb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.